Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agentsUwe J. Ries, Herbert Nar, Henning Priepke et al.|Bioorganic & Medicinal Chemistry Letters|2003Cited by 80
A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer stateGisela Schnapp, Dennis Fiegen, Frank Büttner et al.|Communications Chemistry|2020Cited by 22
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of CancerChristian A. Kuttruff, Thorsten Oost, Martin Fleck et al.|Journal of Medicinal Chemistry|2023Cited by 15
Heterocyclic Thrombin Inhibitors. Part 2. Quinoxalinone Derivatives as Novel, Potent Antithrombotic Agents.Uwe J. Ries, Herbert Nar, Henning Priepke et al.|ChemInform|2003Cited by 0